Market Place
Sourcing Support
Biocon Appoints Karthik SM as Head of HR for India, Malaysia
15 Apr 2026 //
INDPHARMAPOST
Biocon Foundation, Best Cluster, And NCBS Launch Biowise Cohort
03 Apr 2026 //
INDPHARMAPOST
Shreehas Tambe appointed CEO & MD of Biocon, effective April 1
28 Mar 2026 //
EXPRESSPHARMA
Bahiafarma, Biocon, Bionovis Inks Mou In Pharma Sector
21 Feb 2026 //
ECONOMICTIMES
Biocon Completes Rs. 4,150 Crore Equity Fundraise Through QIP
15 Jan 2026 //
INDPHARMAPOST
Biocon Signs Out-Licensing Deal For Semaglutide With Ajanta
23 Dec 2025 //
INDPHARMAPOST
Kiran Mazumdar-Shaw Ranked 2Nd Most Generous Woman By Hurun India
21 Nov 2025 //
INDPHARMAPOST
Groups Demand Better Review Practices, Transparency in PDUFA VIII
20 Aug 2025 //
RAPS
Biocon Foundation launches BioWISE Program for Women in STEM
11 Jun 2025 //
INDPHARMAPOST
Indian pharma stocks decline after Trump again threatens tariffs
09 Apr 2025 //
REUTERS
Biocon betting big on new product launches for growth
13 Feb 2025 //
ECONOMICTIMES
Biocon posts Q3 FY25 PAT at Rs. 25 Cr
31 Jan 2025 //
INDPHARMAPOST
Bicon`s Generics Oxcarbazepine Receives Tentative Approval in US
08 Jan 2025 //
FDA
Biocon arm`s growth formula: US rollouts & debt reduction
12 Aug 2024 //
ECONOMICTIMES
Biocon posts Q1 FY25 PAT higher at Rs. 660 Cr
11 Aug 2024 //
INDIANPHARMAPOST
India`s Biocon posts Q1 profit rise on sale of branded formulations business
08 Aug 2024 //
REUTERS
Biocon Foundation And IISc Lead AI-Center Of Excellence Project
30 Jul 2024 //
PHARMABIZ
Biocon inks licensing, supply pact Handok for chronic weight management product
24 May 2024 //
PRESS RELEASE
Biocon net profit for Q4 declines 56%
16 May 2024 //
PHARMABIZ
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
28 Apr 2024 //
ECONOMICTIMES
Biocon receives approval from SAHPRA for Tacrolimus Capsule
22 Apr 2024 //
INDINPHARMAPOST
India`s Biocon developing its own version of Wegovy, trial likely next year
18 Apr 2024 //
REUTERS
Biocon partners Biomm to commercialise diabetes drug in Brazil
17 Apr 2024 //
ECONOMICTIMES
Biocon leads India`s push into anti-obesity drugs as patents lapse
08 Apr 2024 //
BUSINESS STANDARD
Biocon to sell branded formulations business to Eris Lifesciences for $150 mln
13 Mar 2024 //
REUTERS
Novo Nordisk tackles harm from Ozempic fakes with global authorities
09 Mar 2024 //
REUTERS
Biocon gets over Rs 3 crore penalty over GST related issues
23 Feb 2024 //
ECONOMIC TIMES
Biocon CFO Indranil Sen resigns
08 Feb 2024 //
ENDPTS
Pharma industry can be worth $200B by 2030,says Biocon chief Kiran Mazumdar-Shaw
24 Jan 2024 //
ECONOMIC TIMES
Biocon Academy conducts 8th Graduation Day
19 Dec 2023 //
INDIAN PHARMA POST
Biocon looking at options to cut debt taken for Viatris` business buy`
17 Nov 2023 //
ECONOMIC TIMES
India`s Biocon misses Q2 profit view on higher expenses
09 Nov 2023 //
REUTERS
Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada
09 Oct 2023 //
ECONOMIC TIMES
Biocon`s Peter Bains jumps from the board to group CEO
19 Sep 2023 //
FIERCE PHARMA
Biocon appoints Peter Bains as Group CEO
18 Sep 2023 //
ECONOMIC TIMES
Biocon acquires Eywa Pharma`s US-based plant for $7.7 million
02 Sep 2023 //
ECONOMIC TIMES
Biocon Group concludes month-long sustainability initiatives commemorating WED
01 Jul 2023 //
EXPRESS PHARMA
Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
24 May 2023 //
INDIAN PHARMA POST
Biocon Q3 FY23 revenue up 36%
17 Feb 2023 //
INDIAN PHARMA POST
Biocon Biologics recognized as company with Great Managers, two conferred
22 Dec 2022 //
PHARMABIZ
Biocon starts clinical study to evaluate efficacy of Itolizumab
15 Dec 2022 //
ECONOMIC TIMES
Shreehas Tambe Appointed as Managing Director & CEO of Biocon Biologics
05 Dec 2022 //
PRESS RELEASE
Biocon Biologics promotes Shreehas Tambe to MD and CEO
04 Dec 2022 //
THEHINDUBUSINESSLINE
Biocon Biologics Completes Acquisition of Viatris` Global Biosimilars Business
30 Nov 2022 //
BIOSPACE
Biocon raises $1.2 billion green loan to fund purchase of Viatris unit
29 Nov 2022 //
ECONOMIC TIMES
Biocon Limited enters into a commercialization agreement with Zentiva in Europe
24 Nov 2022 //
PRESS RELEASE
FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar
19 Nov 2022 //
BIOPHARMADIVE
Biocon got regulatory approvals for acquisition of Viatris` biosimilar business
17 Nov 2022 //
ECONOMIC TIMES
Biocon Q2 revenue up 23% at Rs 2,384 crore, profit dips at 66% to Rs 47 crore
15 Nov 2022 //
PHARMABIZ
Biocon ranks 8th in global top employers’ list by US Science magazine
02 Nov 2022 //
PHARMABIZ
Syngene reports Rs 102 crore net profit in Q2FY23
19 Oct 2022 //
ECONOMIC TIMES
Biocon Biologics inks out-licensing agreement with Yoshindo Inc
17 Oct 2022 //
HEALTH ET
Biocon chief Kiran Mazumdar-Shaw wins H K Firodia Lifetime Award 2022
26 Sep 2022 //
PHARMABIZ
Biocon Biologics receives observations from USFDA: Biocon
01 Sep 2022 //
HEALTHET
Syngene to benefit from rupee depreciation, rising demand for research
31 Aug 2022 //
ECONOMICTIMES
Eris Lifesciences enters licensing deal with Biocon for insulin glargine
05 Aug 2022 //
ECONOMIC TIMES
Allegations `serious` & `grave`, says special court in Biocon Biologics case
23 Jul 2022 //
ET HEALTH
Biocon Biologics Receives EU Good Manufacturing Practice Certification
10 Jul 2022 //
GENENGNEWS
Delhi HC rejects CBI plea for custody of four accused in Biocon case
05 Jul 2022 //
BUSINESS-STANDARD
Biocon arm Syngene ends contract with Bioinnovat Research over graft case
05 Jul 2022 //
BUSINESS-STANDARD
